GlassScriptPhysician profile
Mohit Pasi
NPI 1649279613
$15,703.51
in general payments reported to CMS, 2019-2025
33 companies · $1,092 in 2025
The $1,092 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $781 · 2020: $299 · 2021: $432 · 2022: $747 · 2023: $5,455 · 2024: $6,897 · 2025: $1,092.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $11K · Food and Beverage: $2,444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $11,000.00 |
| Food and Beverage | $2,444.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $11,049.10 | 2023-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Boston Scientific Corporation | $932.19 | 2020-2025 | General - Therapies, Rotapro, Jetstream Sc |
| Abiomed | $421.17 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $350.76 | 2019-2025 | Lifevest |
| Medtronic, INC. | $346.52 | 2022-2024 | Onyx Frontier, In.Pact Admiral |
| Actelion Pharmaceuticals US, INC. | $302.64 | 2019-2024 | Opsumit, Uptravi |
| Abbott Laboratories | $300.17 | 2021-2025 | Coroflow, Jeti Peripheral Catheter |
| E.R. Squibb & Sons, L.L.C. | $280.64 | 2021-2025 | Camzyos, Eliquis |
| Shockwave Medical, INC | $232.57 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $183.93 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.05 | 2019-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $147.65 | 2025 | Amvuttra |
| Amgen INC. | $145.91 | 2020-2025 | Repatha, Repatha |
| Irhythm Technologies, INC. | $143.87 | 2024 | Zio Monitor, Zio Xt Patch |
| Novartis Pharmaceuticals Corporation | $141.58 | 2019-2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $113.85 | 2019-2024 | Farxiga |
| Asahi Intecc USA, INC. | $66.65 | 2021 | |
| Janssen Pharmaceuticals, INC | $62.48 | 2019-2023 | Xarelto |
| Baxter Healthcare | $48.90 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Lexicon Pharmaceuticals, INC. | $37.56 | 2023-2024 | Inpefa |
| Cordis US Corp. | $34.22 | 2025 | Mynxgrip |
| Celgene Corporation | $32.51 | 2022-2023 | Camzyos |
| Edwards Lifesciences Corporation | $22.47 | 2019 | |
| Esperion Therapeutics, INC. | $19.23 | 2024 | Nexletol |
| Cook Medical LLC | $18.75 | 2023 | Micropuncture |
| Cardiva Medical, INC. | $16.32 | 2025 | Cardiva Vascade 6/7f Vcs |
| Sirtex Medical INC | $15.80 | 2025 | Lava Les (Liquid Embolic System) |
| Davol INC. | $15.28 | 2025 | Arista |
| Heartflow, INC. | $12.74 | 2020 | |
| Sanofi-Aventis U.S. LLC | $12.60 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $12.51 | 2022 | |
| Gilead Sciences, INC. | $11.89 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohit Pasi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.